Thematic 2019 Letter from the Editor

References

• Al-Harbi NO, Imam F,Al-Harbi MM, et al. (2016). Dexamethasone attenuates LPS-induced acute lung injury through, inhibition of NF-KappaB, COX-2, and pro-inflammatory mediators. Immunol Invest, 45(4),349–369.
   PubMed Web of Science ®Google Scholar
• Asarat M, Apostolopoulos V, Vasiljevic T, Donkor O. (2016). Short-chain fatty acids regulate cytokines and Th17/Treg cells in human peripheral blood mononuclear cells in vitro. Immunol Invest, 45(3), 205–222. doi:10.3109/08820139.2015.1122613
   PubMed Web of Science ®Google Scholar
• Azimi M, Aslani S, Mortezagholi S, et al. (2016). Identification, isolation, and functional assay of regulatory T cells. Immunol Invest, 45(7), 584–602. doi:10.1080/08820139.2016.1193869
   PubMed Web of Science ®Google Scholar
• Banach M, Robert J. (2019). Evolutionary underpinnings of innate-like T cell interactions with cancer. Immunol Invest, 48(7), 1–22. doi:10.1080/08820139.2019.1631341
   PubMed Web of Science ®Google Scholar
• Baric A, Brcic L, Gracan S, et al. (2019). Thyroglobulin antibodies are associated with symptom burden in patients with Hashimoto’s thyroiditis: A cross-sectional study. Immunol Invest, 48(2), 198–209. doi:10.1080/08820139.2018.1529040
   PubMed Web of Science ®Google Scholar
• Bos PD. (2016). TREG cells in cancer: beyond classical immunological control. Immunol Invest, 45(8), 721–728. doi:10.1080/08820139.2016.1222206
   PubMed Web of Science ®Google Scholar
• Cao Y, Huang H, Wang Z, Zhang G. (2017). The inflammatory CXC chemokines, GROαhigh, IP-10low, and MIGlow, in tumor microenvironment can be used as new indicators for non-small cell lung cancer progression. Immunol Invest, 46(4), 361–374. doi:10.1080/08820139.2017.1280052
   PubMed Web of Science ®Google Scholar
• Chao DT, Ma X, Li O, et al. (2009). Functional characterization of N297A, a murine surrogate for low-Fc binding anti-human CD3 antibodies. Immunol Invest, 38(1), 76–92. doi:10.1080/08820130802608238
   PubMed Web of Science ®Google Scholar
• Egilmez N, Li Q. (2016). Ontogeny of tumor-associated CD4+CD25+Foxp3+ T-regulatory cells. Immunol Invest, 45(8), 729–745.
   Web of Science ®Google Scholar
• Elwan N, Salem ML, Kobtan A, et al. (2018). High numbers of myeloid derived suppressor cells in peripheral blood and ascitic fluid of cirrhotic and HCC patients. Immunol Invest, 47(2), 169–180. doi:10.1080/08820139.2017.1407787
   PubMed Web of Science ®Google Scholar
• Fathi F, Faghih Z, Khademi B, et al. (2019). PD-1 haplotype combinations and susceptibility of patients to squamous cell carcinomas of head and neck. Immunol Invest, 48(1), 1–10. doi:10.1080/08820139.2018.1538235
   PubMed Web of Science ®Google Scholar
• Fu G, Miao L, Wang M, et al. (2017). The postoperative immunosuppressive phenotypes of peripheral T helper cells are associated with poor prognosis of breast cancer patients. Immunol Invest, 46(7), 647–662. doi:10.1080/08820139.2017.1360337
   PubMed Web of Science ®Google Scholar
• Gao Y, Zhou S, Jiang W, et al. (2003). Effects of Ganopoly® (A ganoderma lucidum polysaccharide extract) on the immune functions in advanced‐stage cancer patients. Immunol Invest, 32(3), 201–215. doi:10.1081/IMM-120022979
   PubMed Web of Science ®Google Scholar
• Gaur P, Shukla NK, Das SN. (2017). Phenotypic and functional characteristics of Th17 (CD4+IL17A+) cells in human oral squamous cell carcinoma and its clinical relevance. Immunol Invest, 46(7), 689–702. doi:10.1080/08820139.2017.1360344
   PubMed Web of Science ®Google Scholar
• Harden JL, Egilmez NK. (2012). Indoleamine 2,3-dioxygenase and dendritic cell tolerogenicity. Immunol Invest, 41(6–7), 738–764. doi:10.3109/08820139.2012.676122
   PubMed Web of Science ®Google Scholar
• Hirosaki H, Maeda Y,Shimojima M, et al. (2019). Effects of soluble tumor necrosis factor (TNF) on antibody dependent cellular cytotoxicity of therapeutic anti-TNF-? Antibody. Immunol Invest, 48(5), 441–445.
   PubMed Web of Science ®Google Scholar
• Hwang H-SA, Han R, Lee JY, et al. (2019). Enhanced anti-leukemic effects through induction of immunomodulating microenvironment by blocking CXCR4 and PD-L1 in an AML mouse model. Immunol Invest, 48(1), 96–105. doi:10.1080/08820139.2018.1497057
   PubMed Web of Science ®Google Scholar
• Jahromi N, Fatemeh MS, Mojtahedi Z, et al. (2017). Association of PD-1.5 C/T, but not PD-1.3 G/A, with malignant and benign brain tumors in Iranian patients. Immunol Invest, 46(5), 469–480. doi:10.1080/08820139.2017.1296858
   PubMed Web of Science ®Google Scholar
• Jensen-Smith H, Gray B, Muirhead K, et al. (2007). Long-distance three-color neuronal tracing in fixed tissue using NeuroVue dyes. Immunol Invest, 36(5–6), 763–789. doi:10.1080/08820130701706711
   PubMedGoogle Scholar
• Jung N-C, Lee J-H, Choi H-J, et al. (2016). Dendritic cell immunotherapy combined with cytokine-induced killer cells effectively suppresses established hepatocellular carcinomas in mice. Immunol Invest, 45(6), 553–565. doi:10.1080/08820139.2016.1183025
   PubMed Web of Science ®Google Scholar
• Kazemi Sefat, N.A., Mohammadi, M.M., Hadjati, J., Talebi, S., Ajami, M., Daneshvar, H., (2019). Sodium Butyrate as a Histone Deacetylase Inhibitor Affects Toll-Like Receptor 4 Expression in Colorectal Cancer Cell Lines. Immunological investigations, 48(7)
   Google Scholar
• Kirkwood KL. (2018). Inflammaging. Immunol Invest, 47(8), 770–773. doi:10.1080/08820139.2018.1552392
   PubMed Web of Science ®Google Scholar
• Kohnepoushi C, Nejati V, Delirezh N, Biparva P. (2019). Poly lactic-co-glycolic acid nanoparticles containing human gastric tumor lysates as antigen delivery vehicles for dendritic cell-based antitumor immunotherapy. Immunol Invest, 48(7), 1–15. doi:10.1080/08820139.2019.1610889
   PubMed Web of Science ®Google Scholar
• Li N, Fan X, Wang X, et al. (2019a). Autophagy-related 5 gene rs510432 polymorphism is associated with hepatocellular carcinoma in patients with chronic hepatitis B virus infection. Immunol Invest, 48(4), 378–391. doi:10.1080/08820139.2019.1567532
   PubMed Web of Science ®Google Scholar
• Li X, Darby J, Lyons AB, et al. (2019b). TNF may negatively regulate phagocytosis of devil facial tumour disease cells by activated macrophages. Immunol Invest, 48(7), 1–13. doi:10.1080/08820139.2018.1515222
   Google Scholar
• Liu W, Almo SC, Zang X. (2016). Co-stimulate or co-inhibit regulatory T cells, which side to go? Immunol Invest, 45(6), 813–831. doi:10.1080/08820139.2016.1186690
   Web of Science ®Google Scholar
• Liu XG, Hou M, Liu Y. (2017). TIGIT, A novel therapeutic target for tumor immunotherapy. Immunol Invest, 46(2), 172–182. doi:10.1080/08820139.2016.1237524
   PubMed Web of Science ®Google Scholar
• Ma H, Mao G, Zhang G, Huang H. (2017). The expression and clinical signification of PD-1 in lymph nodes of patients with non-small cell lung cancer. Immunol Invest, 46(7), 639–646. doi:10.1080/08820139.2017.1341521
   PubMed Web of Science ®Google Scholar
• Maccalli C, Parmiani G, Ferrone S. (2017). Immunomodulating and immunoresistance properties of cancer-initiating cells: implications for the clinical success of immunotherapy. Immunol Invest, 46(3), 221–238. doi:10.1080/08820139.2017.1280051
   PubMed Web of Science ®Google Scholar
• Manjili M, Butler SE. (2016). Role of Tregs in cancer dormancy or recurrence. Immunol Invest, 45(8), 759–766. doi:10.1080/08820139.2016.1194428
   Web of Science ®Google Scholar
• Monzavi-Karbassi B, Kieber-Emmons T. (2016). Tumor-associated glycans and Tregs in immunogenicity of an autologous cell-based vaccine. Immunol Invest, 45(8), 746–758. doi:10.1080/08820139.2016.1219865
   Web of Science ®Google Scholar
• Mosayebi G, Ghazavi A, Ghasami K, et al. (2011). Therapeutic effect of vitamin D3 in multiple sclerosis patients. Immunol Invest, 40(6), 627–639. doi:10.3109/08820139.2011.573041
   PubMed Web of Science ®Google Scholar
• Obermajer N, Wong JL, Edwards RP, et al. (2012). PGE2-driven induction and maintenance of cancer-associated myeloid-derived suppressor cells. Immunol Invest, 41(6–7), 635–657. doi:10.3109/08820139.2012.695417
   PubMed Web of Science ®Google Scholar
• Oh S, Lee H, Shin JH, et al. (2018). Murine CD8+ invariant natural killer T cells are negatively selected by CD1d expressed on thymic epithelial cells and dendritic cells. Immunol Invest, 47(1), 89–100. doi:10.1080/08820139.2017.1385621
   PubMed Web of Science ®Google Scholar
• Ouni N, Chaaben AB, Kablouti G, et al. (2017). MICA-129Met/Val polymorphism is associated with early-onset breast cancer risk. Immunol Invest, 46(6), 603–614. doi:10.1080/08820139.2017.1336175
   PubMed Web of Science ®Google Scholar
• Owen RS, Siddle HV. (2019). Devil facial tumours: towards a vaccine. Immunol Invest, 48(7), 1–18. doi:10.1080/08820139.2019.1624770
   PubMed Web of Science ®Google Scholar
• Pockley AG, Shepherd J, Corton JM. (1998). Detection of heat shock protein 70 (HSP70) and anti-HSP70 antibodies in the serum of normal individuals. Immunol Invest, 27(6), 367–377. doi:10.3109/08820139809022710
   PubMed Web of Science ®Google Scholar
• Raber P, Ochoa AC, Rodríguez PC. (2012). Metabolism of L-arginine by myeloid-derived suppressor cells in cancer: mechanisms of T cell suppression and therapeutic perspectives. Immunol Invest, 41(6–7), 614–634. doi:10.3109/08820139.2012.680634
   PubMed Web of Science ®Google Scholar
• Robert J. (2019). Introduction to “Comparative and evolutionary aspects of tumor immunity”. Immunol Invest, 48.
   Google Scholar
• Salmaninejad A, Zamani MR, Pourvahedi M, et al. (2016). Cancer/testis antigens: expression, regulation, tumor invasion, and use in immunotherapy of cancers. Immunol Invest, 45(7), 619–640. doi:10.1080/08820139.2016.1197241
   PubMed Web of Science ®Google Scholar
• Sanguinete MMM, Oliveira PHD, Martins-Filho A, et al. (2017). Serum IL-6 and IL-8 correlate with prognostic factors in ovarian cancer. Immunol Invest, 46(7), 677–688. doi:10.1080/08820139.2017.1360342
   PubMed Web of Science ®Google Scholar
• Sawaisorn P, Tangchaikeeree T, Chan-On W, et al. (2019). Antigen-presenting cell characteristics of human γδ T lymphocytes in chronic myeloid leukemia. Immunol Invest, 48(1), 11–26. doi:10.1080/08820139.2018.1529039
   PubMed Web of Science ®Google Scholar
• Sevmis M, Yoyen-Ermis D, Aydin C, et al. (2017). Splenectomy-induced leukocytosis promotes intratumoral accumulation of myeloid-derived suppressor cells, angiogenesis and metastasis. Immunol Invest, 46(7), 663–676. doi:10.1080/08820139.2017.1360339
   PubMed Web of Science ®Google Scholar
• Shimizu Y, Matsumoto K, Okayama Y, et al. (2008). Interleukin-3 does not affect the differentiation of mast cells derived from human bone marrow progenitors. Immunol Invest, 37(1), 1–17. doi:10.1080/08820130701741742
   PubMed Web of Science ®Google Scholar
• Singh M, Loftus T, Webb E, Benencia F. (2016). Minireview: regulatory T cells and ovarian cancer. Immunol Invest, 45(8), 712–720. doi:10.1080/08820139.2016.1186689
   Web of Science ®Google Scholar
• Souza PPC, Lerner UH. (2013). The role of cytokines in inflammatory bone loss. Immunol Invest, 42(7), 555–622. doi:10.3109/08820139.2013.822766
   PubMed Web of Science ®Google Scholar
• Spacek J, Vocka M, Netikova I, et al. (2018). Immunological examination of peripheral blood in patients with colorectal cancer compared to healthy controls. Immunol Invest, 47(7), 643–653. doi:10.1080/08820139.2018.1480030
   PubMed Web of Science ®Google Scholar
• Tomar MS, Kumar S, Kumar S, et al. (2018). NK cell effector functions regulation by modulating nTreg cell population during progressive growth of Dalton’s lymphoma in mice. Immunol Invest, 47(1), 40–56. doi:10.1080/08820139.2017.1368545
   PubMed Web of Science ®Google Scholar
• Wang K, Vella AT. (2016). Regulatory T cells and cancer: a two-sided story. Immunol Invest, 45(8), 797–812. doi:10.1080/08820139.2016.1197242
   PubMed Web of Science ®Google Scholar
• Wang L, Fan J, Ye W, et al. (2019). The expression of ILT4 in myeloid dendritic cells in patients with hepatocellular carcinoma. Immunol Invest, 48(7), 1–15. doi:10.1080/08820139.2019.1571507
   PubMed Web of Science ®Google Scholar
• Wang T, Shi W, Fan T, et al. (2016). c-rel is required for the Induction of pTregs in the eye but not in the Gut Mucosa. Immunol Invest, 45(8), 776–786. doi:10.3109/08820139.2016.1172639
   Web of Science ®Google Scholar
• Zeng Y. (2019). Cloning and analysis of the multiple transcriptomes of serine protease homologs in crayfish (Procambarus clarkii). Immunol Invest, 48(7), 1–9. doi:10.1080/08820139.2018.1509870
   PubMedGoogle Scholar
• Zhang M, Yang J, Zhou J, et al. (2019). Prognostic values of CD38+CD101+PD1+CD8+ T cells in pancreatic cancer. Immunol Invest, 48(5), 466–479. doi:10.1080/08820139.2019.1566356
   PubMed Web of Science ®Google Scholar